Biolojic is eligible to receive up to $121 million, consisting of potential milestones and a promissory note, as well as tiered royalties INDIANAPOLIS and TEL AVIV , March 8, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Biolojic Design Ltd.

INDIANAPOLIS , March 8, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on Tuesday, March 9, 2021 . Patrik Jonsson , senior vice president, president of Lilly USA and chief customer officer, will participate in a virtual fireside

CHMP has completed a review of available data for both antibodies for the treatment of confirmed COVID-19 CHMP scientific opinion supports national decision-making within European Union (EU) member states on the use of the antibodies during a public health emergency before a formal marketing

INDIANAPOLIS , March 5, 2021 /PRNewswire/ -- Loxo Oncology at Lilly , a research and development group of Eli Lilly and Company (NYSE: LLY), today announced that The Lancet has published data from the pirtobrutinib (previously referred to as LOXO-305) global Phase 1/2 BRUIN clinical trial in